Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The BE (2)-M17 neuroblastoma cell line: revealing its potential as a cellular model for Parkinson’s disease

26 Nov 2024

Abstract excerpt

models available. Among these, the SH-SY5Y neuroblastoma cell line is one of the most employed. This model expresses catecholaminergic markers and can differentiate and acquire various neuronal phenotypes. However, challenges persist, primarily concerning the variability of growth media, expression of dopaminergic markers, and a wide variety of differentiation protocols have been reported in the literature...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nerve injury and regeneration
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39659447
DOI: 10.3389/fncel.2024.1485414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The BE (2)-M17 neuroblastoma cell line: revealing its potential as a cellular model for Parkinson’s diseasePMID 39659447Read ↗

The BE (2)-M17 cell line has a better dopaminergic phenotype than the traditionally used for Parkinson´s research SH-SY5Y, which is mostly serotonergic.Semantic proximity Read ↗

The BE (2)-M17 cell line has a better dopaminergic phenotype than the traditionally used for Parkinson´s research SH-SY5Y, which is mostly serotonergicSemantic proximity Read ↗

Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.Semantic proximity Read ↗

Differentiation of the SH-SY5Y Human Neuroblastoma Cell LineSemantic proximity Read ↗

Differentiation of the SH-SY5Y Human Neuroblastoma Cell LineSemantic proximity Read ↗

The role of neuron-like cell lines and primary neuron cell models in unraveling the complexity of neurodegenerative diseases: a comprehensive reviewSemantic proximity Read ↗

Enhanced yield and subtype identity of hPSC-derived midbrain dopamine neuron by modulation of WNT and FGF18 signalingSemantic proximity Read ↗

Neural regeneration research model to be explored: SH-SY5Y human neuroblastoma cellsSemantic proximity Read ↗

A Novel and Robust Protocol for Differentiation of SH-SY5Y Neuroblastoma Cells into Neuron Like CellsSemantic proximity Read ↗

Development of a Disease Modeling Framework for Glutamatergic Neurons Derived from Neuroblastoma Cells in 3D MicroarraysSemantic proximity Read ↗

Methods used to achieve different levels of the neuronal differentiation process in SH‐SY5Y and Neuro2a cell lines: An integrative reviewSemantic proximity Read ↗

Neuroblastoma Cell Lines-A Versatile in Vztro Model in NeurobiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.